Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.

Jayaram A, Rashid M, Reid AHM, Orlando F, Thakali S, Zakka L, Goncalves M, O'Dwyer J, Alifrangis C, Jones R, Pintus E, Needleman S, Bianchini D, Wingate A, Ng K, Linch M, McGovern U, Staffurth J, Crabb SJ, Brock S, Birtle A, Vainauskas O, Leone G, Chiwewe M, Hackshaw A, Lopes A, Wetterskog D, Demichelis F, Attard G

Open source

DOI: 10.1038/s43018-026-01172-9
Published: 2026 Jun
Container: Nature cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-026-01172-9,
  title = {Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.},
  author = {Jayaram A and Rashid M and Reid AHM and Orlando F and Thakali S and Zakka L and Goncalves M and O'Dwyer J and Alifrangis C and Jones R and Pintus E and Needleman S and Bianchini D and Wingate A and Ng K and Linch M and McGovern U and Staffurth J and Crabb SJ and Brock S and Birtle A and Vainauskas O and Leone G and Chiwewe M and Hackshaw A and Lopes A and Wetterskog D and Demichelis F and Attard G},
  year = {2026},
  journal = {Nature cancer},
  doi = {10.1038/s43018-026-01172-9},
  url = {https://doi.org/10.1038/s43018-026-01172-9}
}

RIS

TY  - JOUR
TI  - Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.
AU  - Jayaram A
AU  - Rashid M
AU  - Reid AHM
AU  - Orlando F
AU  - Thakali S
AU  - Zakka L
AU  - Goncalves M
AU  - O'Dwyer J
AU  - Alifrangis C
AU  - Jones R
AU  - Pintus E
AU  - Needleman S
AU  - Bianchini D
AU  - Wingate A
AU  - Ng K
AU  - Linch M
AU  - McGovern U
AU  - Staffurth J
AU  - Crabb SJ
AU  - Brock S
AU  - Birtle A
AU  - Vainauskas O
AU  - Leone G
AU  - Chiwewe M
AU  - Hackshaw A
AU  - Lopes A
AU  - Wetterskog D
AU  - Demichelis F
AU  - Attard G
PY  - 2026
JO  - Nature cancer
DO  - 10.1038/s43018-026-01172-9
UR  - https://doi.org/10.1038/s43018-026-01172-9
ER  -

APA

A, J., M, R., AHM, R., F, O., S, T., L, Z., M, G., J, O., C, A., R, J., E, P., S, N., D, B., A, W., K, N., M, L., U, M., J, S., SJ, C., S, B., A, B., O, V., G, L., M, C., A, H., A, L., D, W., F, D., & G, A. (2026). Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.. Nature cancer. https://doi.org/10.1038/s43018-026-01172-9

Source records

pubmed · retrieved 2026-09-26T20:22:11.607Z